Advancing Drug Discovery via M-Optimus

Bioptimus Launches STELA Spatial Biology Atlas

Partnership with 10x Genomics aims to profile 100,000 specimens to accelerate drug discovery and precision medicine.

By Avantgarde News Desk··1 min read
Digital visualization of spatial biology tissue mapping with complex molecular data overlays in a modern laboratory environment.

Digital visualization of spatial biology tissue mapping with complex molecular data overlays in a modern laboratory environment.

Photo: Avantgarde News

Bioptimus has announced the launch of the Spatial Tissue Embedding Learning Atlas, known as STELA, marking a significant milestone in precision medicine [1]. This multinational initiative is a collaborative effort with 10x Genomics and Broad Clinical Labs [2]. The project aims to profile 100,000 patient specimens to build a comprehensive biological dataset [3]. The gathered data will power M-Optimus, a multimodal "world model" of biology designed to enhance drug discovery processes [1][3]. By linking clinical data with spatial biology, the partners intend to accelerate the development of new treatments [2]. This initiative represents the world's largest clinically linked spatial biology atlas currently in development [3].

Editorial notes

Transparency note

Drafted with LLM; human-edited

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

Minimal

Reviewed for sourcing quality and editorial consistency.

Sources

Related stories

View all

Topics

Get the weekly briefing

Weekly brief with top stories and market-moving news.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Avantgarde News Desk covers advancing drug discovery via m-optimus and editorial analysis for Avantgarde News.